Ignyta Appoints Sara Zaknoen, M.D., As Chief Medical Officer
2/19/2014 7:14:34 AM
Ignyta, Inc. (OTCQB:RXDX), an oncology precision medicine biotechnology company, announced today that Sara Zaknoen, M.D., has been appointed as Chief Medical Officer, assuming full-time responsibilities for the role from James L. Freddo, M.D., who was previously serving as Ignyta’s Chief Medical Officer on a consulting basis.
Help employers find you! Check out all the jobs and post your resume.
comments powered by